Clinical Trials in Spain — Country Dashboard | 4,852 EU Studies

Filter these 4,852 trials by condition, phase, sponsor and more.

Open in Search →

4,852 Registered trials

1,874 Recruiting

2,540 Completed trials

1,158 Sponsors active

830 Research sites

Phase III

Phase II

Phase III: 1860 Phase II/III: 196 Phase II: 1247 Phase I/II: 318 Phase III/IV: 55 Phase IV: 271 Phase I: 331 Phase I (Other): 273 Phase I (FiH): 244 Other: 54 Other: 3

Oversight events in trials active here:

133 serious breaches 1020 temporary halts 82 urgent safety measures 101 unexpected events 158 corrective measures across 562 trials

View oversight register →

Top conditions

Non-small cell lung cancer 189 Non-small cell lung cancer metastatic 61 Ovarian cancer 55 Colorectal cancer 48 Breast cancer 48 Systemic lupus erythematosus 41 Endometrial cancer 35 Squamous cell carcinoma of head and neck 35 Myelodysplastic syndrome 32 Diffuse large B-cell lymphoma 30 Triple negative breast cancer 30 Prostate cancer metastatic 29

Top sponsors

AstraZeneca AB 202 Merck Sharp & Dohme LLC 201 Novartis Pharma AG 182 F. Hoffmann-La Roche AG 166 Janssen - Cilag International 145 AbbVie Deutschland GmbH & Co. KG 113 Pfizer Inc. 98 Glaxosmithkline Research & Development Limited 78 Bristol-Myers Squibb Services Unlimited Company 77 Sanofi-Aventis Recherche & Developpement 75 Boehringer Ingelheim International GmbH 72 Amgen Inc. 71

Cities with most trials

All 234 cities →

All trials — page 53

4,852 total

A Phase 2b Study of IMVT-1402 Treatment in CIDP Recruiting

2024-517614-14-00 Phase II Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Immunovant Sciences GmbH
A Phase 2 Randomized, Double-blind Placebo-Controlled Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety and Efficacy of WIN378 … Recruiting

2025-521391-58-00 Phase II Asthma Windward Bio AG
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis Recruiting

2025-521242-26-00 Phase II Moderately to Severely Active Ulcerative Colitis Spyre Therapeutics Inc.
A Phase 3, Multicenter, Randomized, Double-Masked, Vehicle-Controlled Study to Demonstrate Efficacy and Safety of DFL24498 Eye Drop Solution… Recruiting

2025-522291-83-00 Phase III Atopic Keratoconjunctivitis Dompe' Farmaceutici S.p.A.
A phase 3b study of depemokimab on airway structure and function in patients with type 2 asthma utilizing quantitative high-resolution CT an… Recruiting

2024-519976-19-00 Phase III Asthma with type 2 inflammation characterized by an eosinoph… Glaxosmithkline Research & Development Limited
A study to find how well budoprutug (TNT119) works and how safe it is in participants with Systemic Lupus Erythematosus Recruiting

2024-520385-57-01 Phase I (Other) Systemic Lupus Erythematosus Climb Bio Inc.
Subcutaneous Trastuzumab Deruxtecan Phase 1 Trial. Recruiting

2024-516625-31-00 Phase I (Other) Advanced Solid Tumor Daiichi Sankyo Inc.
A Study of the Long-Term Safety and Efficacy of VX-670 in Patients With Myotonic Dystrophy Type I Recruiting

2024-517983-47-00 Phase I/II Myotonic Dystrophy Vertex Pharmaceuticals Inc.
A study to evaluate the safety and efficacy of two dose levels of ONO-4578 with Opdivo®, in combination with mFOLFOX6 and bevacizumab versus… Recruiting

2024-519590-19-00 Phase II PD-L1 positive advanced colorectal cancer Ono Pharmaceutical Co. Ltd.
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors Recruiting

2024-519727-18-00 Phase I Metastatic Solid Tumor Advanced Solid Tumor Non-small Cell L… Eli Lilly & Co.
Darbepoetin in patients candidates for liver transplant: randomized clinical trial Recruiting

2025-521701-41-00 Phase IV hepatic trasplant Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques Augus…
Safety and Efficacy of Tarperprumig in Adult Participants with ANCA-Associated Vasculitis Recruiting

2025-521706-17-00 Phase II Anti-neutrophil cytoplasmic antibody (ANCA)-associated vascu… Alexion Pharmaceuticals Inc.
A clinical study of MK-1084 in people with advanced solid tumors (MK 1084-014) Recruiting

2025-521737-91-00 Phase II Neoplasm malignant with KRAS G12C mutation Merck Sharp & Dohme LLC
Pasritamig vs Placebo in late line Metastatic Castration-resistant Prostate Cancer (mCRPC) Recruiting

2025-520927-26-00 Phase III Metastatic Castration-resistant Prostate Cancer (mCRPC) Janssen Cilag International
Phase 3 trial of eRapa in patients with familial adenomatous polyposis (FAP) Recruiting

2025-522946-37-00 Phase III Familial adenomatous polyposis (FAP) Biodexa Limited; Rapamycin Holdings Inc.
Phase III clinical trial to evaluate the efficacy and safety of specific immunotherapy with mannanconjugated allergoids for the treatment of… Recruiting

2023-508548-23-00 Phase III Aetiological treatment of moderate-to-severe allergic rhinit… Inmunotek S.L.
A Phase 1/2 Study of BMS-986482 Alone or Combination Therapy in Participants with Advanced Solid Tumors Recruiting

2024-516602-28-00 Phase I (FiH) Advanced Solid Tumors Bristol-Myers Squibb Services Unlimited Company
RLY-2608-201-Ph2 Study of RLY-2608 in PROS and PIK3CA Driven Malformations Recruiting

2024-518895-30-00 Phase II PIK3CA Related Overgrowth Spectrum and Malformations Driven … Relay Therapeutics Inc.
Phase II study of lurbinectedin and irinotecan in adult and young adult patients with advanced desmoplastic small round cell tumor (DSRCT) Recruiting

2024-519261-21-00 Phase II Desmoplastic small round cell tumor Italian Sarcoma Group
A Phase 2b Study to Assess the Efficacy and Safety of IMVT-1402 in Patients With Graves' Disease Recruiting

2025-521920-31-00 Phase II Graves’ Disease Immunovant Sciences GmbH
A Follow-Up Shiftability Study of Arbaclofen with an Open-Label Extension for the study of Biomarkers for Treatment for Social Function in C… Recruiting

2023-508407-20-00 Phase III autism spectrum disorder Fundacion Para La Investigacion Biomedica Del Hospital Gregorio Maranon
A Phase 2 Study of CRD-4730 in CPVT Recruiting

2024-515564-32-00 Phase II Catecholaminergic Polymorphic Ventricular Tachycardia Cardurion Pharmaceuticals Inc.
A study to find out whether BI 765423 has an effect on lung function in people with idiopathic pulmonary fibrosis (IPF) with or without stan… Recruiting

2025-520658-12-00 Phase II Idiopathic Pulmonary Fibrosis (IPF) Boehringer Ingelheim Espana S.A.; Boehringer Ingelheim International GmbH
A Phase Ib/II first-in-human, multicentre, open-label, multiple ascending dose study of S230815 in paediatric participants with KCNT1-relate… Recruiting

2024-513332-17-00 Phase I (FiH) KCNT1-related Developmental and Epileptic Encephalopathy Institut De Recherches Internationales Servier IRIS

Showing 1,249–1,272 of 4,852 trials

← All countries